BAB 5

DAFTAR PUSTAKA

1. Calle EE, Kaaks R. Overweight, obesity and cancer: epi- demiological

evidence and proposed mechanisms. Nature Reviews Cancer 2004;4(8):579-
59.
2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahl M. Body-mass index and
incidence of cancer: a systematic review and meta-analysis of prospective
observational studies. The Lancet 2008;371(9612):569-578.
3. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist
2010;15(6):556-565.
4. Globocan.iarc.fr. Fact Sheets by Cancer [Internet]. 2015 [cited 25 September
2015]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
5. depkes.go.id. Pusat data dan informasi kementrian RI [Internet]. 2015 [cited
25 September 2015]. Available from:
http://www.depkes.go.id/resources/download/pusdatin/infodatin/infodatin-
kanker.pdf
6. Sim HG, Cheng CW. Changing Demography of Prostate Cancer in Asia. Eur J
Cancer 2005;41:834-845.
7. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 2001;23:72-81.
8. Nomura A. Body size and prostate cancer. Epidemiol Rev. 2001;23:126-131.
9. Amatrauda JM, Harman SM, Pourmotabbed G, Lockwood DH. Decreased
plasma testosterone and fractional binding of testosterone in obese males. J
Clin Endocrinol Metab 1978;47:268-271.
10. Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand Suppl
1998;723:153-160.
11. Field AE, Colditz GA, Willet WC, Longcope C, McKinlay JB. The relation of
smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex
hormones, and sex hormone-binding globulin in middle aged men. J Clin
Endocrinol Metab 1994;79:1310-1316.
12. Lima N, Cavaliere H, Knobel M, Halpern A, Medeiros-Neto G. Decreased
androgen levels in massively obese men may be associated with impaired
function of the gonadostat. Int J Obes Relat Metab Disord 2000;24:1443-1447.
13. Cotterill AM, Holly JM, Wass JA. The regulation of insuline-like growth
factor binding protein (IGFBP)-1 during prolonged fasting. Clin Endocrinol
(Oxf) 1993;39:357-362.
14. Busby WH, Snyder DK, Clemmons DR. Radioummunoassay of a 26,000-
dalton plasma insulin-like growth factor-binding protein: control by nutritional
variables. J Clin Endocrinol Metab 1998;67:1225-1230.
15. Suikkari AM, Sane T, Seppala M, Yki-Jarvinen H, Karonen SL, Koivisto VA.
Prolonged exercise increases serum insulin-like growth factor-binding protein
concentration. J Clin Endocrinol Metab 1989;68:141-144.
16. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth
factor binding proteins in adolescents with insulin-dependent diabetes. J Clin
Endocrinol Metab 1991;73:964-968.
17. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. Insulin regulates the 35
kDa IGF binding protein in patiens with diabetes melitus. J Endocrinol Invest
1998;11:599-602.
18. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL,
Seppala M. Insulin regulates the serum levels of low molecular weight insulin-
like growth factor-binding protein. J Clin Endocrinol Metab 1998;66:266-272.
19. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos
D, et al. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer
1999;83:15-17.
20. Chan JM, Stampfer MJ, Giovanucci E, Gann PH, Ma J, Wilkinson P, et al.
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective
study. Science 1998;279:536-6.
21. Hsing AW, Chua S, Gao YT, Gentzdchein E, Chang L, Deng J, et al. Prostate
cancer risk and serum levels of insulin and leptin: a population-based study. J
Natl Cancer Inst 2001;93:783-789.
22. Tortora G, Derrickson B. Principles of anatomy & physiology. Hoboken, N.J.:
Wiley; 2011.
23. Moore K, Agur A, Dalley A. Essential clinical anatomy. Baltimore, MD:
Lippincott Williams & Wilkins; 2011.
24. McCance K, Parkinson C. Study guide for Pathophysiology, the biologic basis
for disease in adults and children, sixth edition. St. Louis, Mo.: Mosby; 2010.
25. Rocha VZ, Libby P. The multiple facets of the fat tissue. Thyroid
 2008;18(2):175-183.
26. Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin
resistance. Annu Rev Physiol 2008;70:537-556.
27. Giovannucci E, B. Rimm E, Liu Y, Leitzmann M, Wu K, J. Stampfer M et al.
Body mass index and risk of prostate cancer in U.S. health professionals.
Journal of the National Cancer Institute. 2003;95(16):1240-1244.
28. Kumar V, Abbas AK, Fausto N. Robbins and Cotran pathologic basis of
disease, eight edition. Philadelphia, MD: Saunders; 2009.

29. Lippman SM. Effect of selenium and vitamin E on risk of prostate cancer and
other cancers: the Selenium and Vitamin E Cancer Prevention Trial
(SELECT). J Am Med Assoc 2009;301:39-51.

30. Giovannucci E. A prospective cohort study of vasectomy and prostate cancer

in US men. JAMA 1993;269(7):873.

31. Peterson RE. Vasectomy and the risk of prostate cancer. Am J Epidemiol
1992;135(3):324.

32. Patel AV, Rodriguez C, Jacobs EJ, Solomon L, Thun MJ et al. Recreational
physical activity and risk of prostate cancer in a large cohort of U.S. men.
Cancer Epidemiol Biomarkers Prev 2005; 14: 275-9.
33. McCance K, Huether S. Pathophysiology: the biologic basis for disease ini
adult and children. 6th ed. Philadelphia: Mosby Elsevier; 2010.
34. Giovannucci E, Rimm EB, Wolk A. Calcium and fructose intake in relation to
risk of prostate cancer. Cancer Res 1998;58:442-447.
35. Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC. A
prospective study of physical activity and incident and fatal prostate cancer.
Arch Intern Med 2005;165:1005-1010.
36. Natu S, Dalela D, Goel A, Tandon P, Goel M, Singh K et al. Is central obesity,
hyperinsulinemia and dyslipidemia associated with high-grade prostate
cancer? A descriptive cross-sectional study. Indian Journal of Urology.
2010;26(4):502.
37. Wiener C. Harrison's principles of internal medicine. New York: McGraw-
Hill, Medical Pub. Division; 2008.
38. Nishida C. Appropriate body-mass index for Asian populations and its
implications for policy and intervention strategies. The Lancet.
2004;363(9403):157-163.
39. Hsph.harvard.edu. Measuring Physical Activity | The Nutrition Source |
Harvard T.H. Chan School of Public Health [Internet]. 2015 [cited 30
November 2015]. Available from:
http://www.hsph.harvard.edu/nutritionsource/mets-activity-table/
40. Nhs.uk. Fat: the facts - Live Well - NHS Choices [Internet]. 2015 [cited 30
November 2015]. Available from:
http://www.nhs.uk/Livewell/Goodfood/Pages/Fat.aspx
41. Hosseini M, Alinaghi SAS, Mahmoudi M, McFarland W. A case-control
study of risk factors for prostate cancer in Iran. Acta Medica Iranica.
2010;48(1):61-66.